Vancomycin Aglycon is primarily used in research and development within the pharmaceutical industry. It serves as a key intermediate in the synthesis of vancomycin and its derivatives, which are crucial antibiotics for treating severe infections caused by Gram-positive bacteria. Its role in the development of new antibiotics helps address the growing issue of antibiotic resistance. Additionally, it is utilized in biochemical studies to understand the mechanism of action of glycopeptide antibiotics, particularly in inhibiting bacterial cell wall synthesis. This compound is also explored in the design of novel therapeutic agents targeting resistant bacterial strains.